Page last updated: 2024-12-08

he 11

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nibentan: MF: C22-H29-N3-O3 HCl; MF does not agree with chemical name in text [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID177905
SCHEMBL ID9571826
MeSH IDM0274184

Synonyms (22)

Synonym
150491-98-8
nibentan
n-[5-(diethylamino)-1-phenylpentyl]-4-nitrobenzamide hydrochloride
AKOS005111093
n4s59zcs33 ,
unii-n4s59zcs33
157832-56-9
he 11
benzamide, n-(5-(diethylamino)-1-phenylpentyl)-4-nitro-, monohydrochloride
n-(5-(diethylamino)-1-phenylpentyl)-4-nitrobenzamide hydrochloride
FT-0682659
SCHEMBL9571826
benzamide, n-(5-(diethylamino)-1-phenylpentyl)-4-nitro-, hydrochloride (1:1)
nibentan [who-dd]
1-phenyl-1-((p-nitrobenzoyl)amino)-5-(n,n-diethylamino)pentane hydrochloride
n-[5-(diethylamino)-1-phenylpentyl]-4-nitrobenzamide;hydrochloride
DTXSID70933957
n-[5-(diethylamino)-1-phenylpentyl]-4-nitrobenzamide--hydrogen chloride (1/1)
(rs)-4-nitro-n-[1-phenyl-5-(diethylamino) pentyl]benzamide hydrochloride
Q27284549
n-(5-(diethylamino)-1-phenylpentyl)-4-nitrobenzamidehydrochloride
benzamide, n-[5-(diethylamino)-1-phenylpentyl]-4-nitro-, hydrochloride (1:1)

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The most significant adverse effect was bradicardia, which was registered more often in the PC group than in EC group (26."( [Comparison of the efficacy and safety of electrical cardioversion and pharmacological cardioversion with nibentan in patients with persisting atrial fibrillation and flutter].
Giliarov, MIu; Novikova, NA; Suchkova, SA; Sulimov, VA; Syrkin, AL, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (17.65)18.2507
2000's13 (76.47)29.6817
2010's1 (5.88)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.43 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index60.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (47.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]